US Stock MarketDetailed Quotes

ARQT Arcutis Biotherapeutics

Watchlist
  • 8.490
  • -0.010-0.12%
Close Aug 16 16:00 ET
  • 8.520
  • +0.030+0.35%
Post 20:01 ET
992.40MMarket Cap-4994P/E (TTM)

Arcutis Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Arcutis Biotherapeutics Q2 2024 Earnings Date

Currency：USDAug 14, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
29.08M
30.86M
+1.78M
Beat Est.
+460.31%
+494.57%
+6.11%
EPS
-0.51
-0.42
+0.09
Beat Est.
+55.82%
+63.79%
+18.03%
Analyst Rating
Strong Buy

Aug 15, 2024

Arcutis Biotherapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 46.211M--
--2024/Q3-- / 36.620M--
Aug 14, 20242024/Q230.858M / 29.080M--
May 14, 20242024/Q149.569M / 15.140M--
Feb 27, 20242023/Q413.526M / 11.388M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 46.211M--
--2024/Q3-- / 36.620M--
Aug 14, 20242024/Q230.858M / 29.080M--
May 14, 20242024/Q149.569M / 15.140M--
Feb 27, 20242023/Q413.526M / 11.388M--

Unlock Free Earnings Estimates

Arcutis Biotherapeutics Earnings Reports

  • Arcutis Biotherapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 14 16:18 ET

  • Arcutis Biotherapeutics | 10-Q/A: Quarterly report (Amendment)

    Jul 24 16:15 ET

  • Arcutis Biotherapeutics | 10-Q: Q1 2024 Earnings Report

    May 14 22:21 ET

  • Arcutis Biotherapeutics | 10-K: FY2023 Annual Report

    Feb 27 07:50 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 15, 2024

    Strong Buy

    • Buy

      80.00%

    • Hold

      20.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg